Promising first-in-human study results for orally inhaled antibiotic

Safety results from a first-in-human study showed that orally inhaled macrocycle compound murepavadin was well tolerated at all dose levels.

Related Keywords

Juergen Froehlich ,European Innovative Medicines Initiative ,Outer Membrane Protein Targeting Antibiotics ,Chief Medical Officer ,